LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/New Limb-Lengthening Surgery Performed
Large Joints and Extremities

New Limb-Lengthening Surgery Performed

March 4, 2014 2 min read Premium comments

Advertisement

New Limb-Lengthening Surgery Performed
Precice Limb Lengthening System / Courtesy: Ellipse Technologies, Inc.
Secondary

Two Baltimore surgeons have performed the first surgery in North America using the P2—the latest generation of Ellipse Technologies, Inc.’s Precice Limb Lengthening System. John Herzenberg, M.D., the director of the Rubin Institute’s International Center for Limb Lengthening (ICLL) and Shawn Standard, M.D., head of Pediatric Orthopedics at the ICLL, inserted the P2 rod into the tibia of a patient at Sinai Hospital earlier this year.

According to a report by LifeBridge Health, the Precice Limb Lengthening System was the first externally controllable internal limb lengthening system to receive clearance by the FDA. The system was co-developed by Standard and Herzenberg in collaboration with Ellipse Technologies of Irvine, California, and Stuart Green, M.D., clinical professor of orthopedic surgery, University of California, Irvine. Launched in early 2012, the first generation of the Precice was the first fully controllable internal limb lengthening system available to medical professionals.

“The Precice Limb Lengthening System represented a revolutionary advancement in the field of limb lengthening, ” said Herzenberg. “This introduction of the P2 is the next step in this ongoing evolution. The Precice system has been a great success at the Rubin Institute. Since 2012, the ICLL has performed 100 surgeries using the initial Precice. We expect similar results with the new P2, along with expanded applicability to younger and smaller patients, because the P2 nail is available in a smaller size (8.5 mm diameter) compared to the original Precice nail.”

The Precice Limb Lengthening System uses a telescopic titanium rod surgically implanted in either the femur or tibia in conjunction with an external remote controller to internally lengthen bones in the leg. Inside the rod, a miniature magnetic motor and gear box create the force needed to lengthen the rod. The power to drive the internal motor is supplied by a magnetic field generator that is held on the skin next to the leg several times a day for a few minutes.

Limb lengthening is used to treat upper and lower limb length deformities. Ellipse officials explain that through this process, new bone and soft tissues are gradually grown. The new growth is called distraction osteogenesis. Bone and soft tissue regenerate when they are slowly pulled apart at a rate of approximately 1 mm per day.

Herzenberg said that, “The Precice internal nail offers patients a more comfortable alternative, with less pain, and less risk of infection, compared to external fixators. The Precice nail has been a game-changer for our patients.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy